Ford Motor Company vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Ford Motor Company trades at $12.17 (market cap $48.85B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.64 (market cap $2.27B). The key difference: Ford Motor Company is far larger — about 21.5× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Ford Motor Company pays a 4.9% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| F | SLS | |
|---|---|---|
Market Cap | $48.85B | $2.27B |
Volume | 57,748,965 | 4,179,659 |
Sector | Consumer Cyclical | Health |
52-Week High | $17.44 | $15.46 |
52-Week Low | $11.21 | $1.39 |
Typical Hold Time | 105 Days | — |
Enterprise Value | $180.81B | $2.14B |
Dividend Yield | 4.9% | — |
Signals from Pluang's Aura AI — not financial advice
Ford Motor Company (F) trades at $12.17, up 0.37% with a bearish technical outlook despite recent earnings beats. The company shows mixed fundamentals with $187.27B revenue but negative net income margin of -3.93% and concerning debt-to-asset ratio of 56.49%. Recent news highlights sales declines and production challenges, though the company maintains strong cash flow from operations of $21.28B. Analyst consensus remains cautiously optimistic with a $15.90 price target despite near-term headwinds.
Ford faces significant execution risks amid declining sales and competitive pressures, but valuation metrics appear attractive with P/E of 11.21 and P/S of 0.26. The hybrid vehicle transition and strong commercial division provide potential upside, though investors must weigh debt levels and margin pressures against the discounted valuation and analyst price target suggesting 30% upside potential.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Ford Motor Company designs, manufactures, and services cars and trucks. The Company also provides vehicle-related financing, leasing, and insurance through its subsidiary.
Read more on F →SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →